Дополнительно

48. Статистика умственной отсталости в России на 2022 год: последние данные и анализ [Электронный ресурс] URL https://ecofornia.ru/statistika-umstvennoj-otstalosti-v-rossii-na-2022-god-poslednie-dannye-i-analiz/#umstvennaya-otstalost-u-detej-trevozhnye-tendencii (дата обращения 15.10.2023)

49. Aman MG, Gharabawi GM; Special Topic Advisory Panel on Transitioning to Risperidone Therapy in Patients With Mental Retardation and Developmental Disabilities. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone. J Clin Psychiatry. 2004 Sep; 65(9):1197-210. PMID: 15367046.

50. Grabowski SW. Haloperidol for control of severe emotional reactions in mentally retarded patients. DisNervSyst. 1973 Aug-Sep; 34(6):315-7. PMID: 4782288.

51. Nezu CM, Nezu AM. Outpatient psychotherapy for adults with mental retardation and concomitant psychopathology: research and clinical imperatives. J ConsultClinPsychol. 1994 Feb; 62(1):34-42. doi: 10.1037//0022-006x.62.1.34. PMID: 8034826.

52. Mousavi SG, Mirnezafat S, Tarrahi MJ. Comparison of Haloperidol, Promethazine, Trifluoperazine, and Chlorpromazine in Terms of Velocity and Durability of the Sedation among Acute Aggressive Patients: A Randomized Clinical Trial. Adv Biomed Res. 2019 Jun 28;8:43. doi: 10.4103/abr.abr_229_18. PMID: 31360684; PMCID: PMC6621353.

53. Беккер, Р. А. Клиническое применение перициазина (Неулептила)/Р.А. Беккер, Ю.В. Быков // Психиатрия и психофармакотерапия. - 2018. - Т. 20, N 2. - С. 16 - 31.

54. Быков, Ю.В. Хлорпротиксен: обзор применения в психиатрии (I часть)/Ю.В. Быков, Р.А. Беккер // Психиатрия и психофармакотерапия. - 2016. - Т. 18, N 2. - С. 26 - 32.

55. Tyrer P, Oliver-Africano P, Romeo R, Knapp M, Dickens S, Bouras N, Ahmed Z, Cooray S, Deb S, Murphy D, Hare M, Meade M, Reece B, Kramo K, Bhaumik S, Harley D, Regan A, Thomas D, Rao B, Karatela S, Len tre L, Watson J, Soni A, Crawford M, Eliahoo J, North B. Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID). Health Technol Assess. 2009 Apr; 13(21):iii-iv, ix-xi, 1-54. doi: 10.3310/hta13210. PMID: 19397849.